Biologically active molecules, conjugates thereof, and therapeutic uses
AssigneeRegeneron Pharmaceuticals, Inc.
InventorThomas NITTOLI
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to linker compounds that are useful in covalently linking biologically active molecules with Ligands. The disclosed compounds also relate to biologically active molecules and Ligand conjugates, wherein the biologically active molecule is linked to the Ligand through a linker. The disclosure further provides compositions comprising biologically active molecule-ligand conjugates, methods of modifying abnormal cell growth and methods of treatment using the conjugates or the compositions.
Claims22
-47. (canceled)
A method of killing a cell, comprising contacting the cell with a composition in an amount sufficient to kill the cell, wherein the cell is killed, wherein the composition comprises a compound, and wherein the compound has the following formula:
- or a pharmaceutically acceptable salt thereof, or an antibody conjugate thereof,
- wherein A3a is —CH2—, —CH2CH2—, or —CH2CH2CH2CH2—;
- and
- R4a is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl.
A method of treatment of a medical disorder in an individual suffering from the medical disorder, comprising administering to the individual an effective amount of a composition comprising a compound, wherein the compound has the following formula:
- or a pharmaceutically acceptable salt thereof, or an antibody conjugate thereof,
- wherein A3a is —CH2—, —CH2CH2—, or —CH2CH2CH2CH2—;
- and
- R4a is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl.
Dependencies are inferred from the claim text.